ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Emory University Has Drug Venture

by Michael McCoy
June 17, 2013 | APPEARED IN VOLUME 91, ISSUE 24

Emory University has launched a public-private drug development enterprise that it says will move scientific discoveries more rapidly from university laboratories to the marketplace. Drug Innovation Ventures at Emory, or Drive, is a nonprofit that will combine the expertise of Emory scientists with a business development and management team, the school says. Drive will function as the “industrial partner” of the four-year-old Emory Institute for Drug Development, founded by Emory chemist Dennis Liotta. Its initial efforts will be financed by $10 million in royalties from the Gilead Sciences HIV drug Emtriva, which Liotta coinvented.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment